Bioxytran, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Accounts Receivable | — | — | — | — | — | — | $50.0K | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $513.5K | $5.2K | $26.1K | $295.4K | $72.4K | $316.4K | $219.6K | $36.4K |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $145.1K | $133.5K | $113.3K | $75.5K | $46.9K | $10.0K | — | — |
| Total Assets | $658.6K | $138.7K | $139.4K | $370.9K | $119.3K | $326.4K | $219.6K | $36.4K |
| Liabilities | ||||||||
| Accounts Payable | $849.6K | $278.3K | $302.7K | $753.8K | $624.3K | $348.1K | $71.9K | $23.4K |
| Total Current Liabilities | $3.2M | $1.9M | $3.2M | $3.7M | $3.3M | $2.3M | $1.0M | $261.7K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $3.2M | $1.9M | $3.2M | $3.7M | $3.3M | $2.3M | $1.0M | $261.7K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-21.0M | $-18.9M | $-15.7M | $-11.2M | $-8.8M | $-4.7M | $-2.2M | $-382.8K |
| Total Stockholders' Equity | $-2.6M | $-1.8M | $-3.1M | $-3.3M | $-3.2M | $-1.9M | $-799.3K | $-225.3K |